Erin Wright
Stock Analyst at Morgan Stanley
(4.48)
# 1,634
Out of 5,182 analysts
261
Total ratings
63.93%
Success rate
14.03%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSIC Henry Schein | Maintains: Underweight | $61 → $64 | $72.02 | -11.14% | 7 | Apr 24, 2026 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $128 → $146 | $195.53 | -25.33% | 5 | Apr 24, 2026 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $19 → $21 | $25.81 | -18.64% | 10 | Apr 24, 2026 | |
| ALGN Align Technology | Maintains: Equal-Weight | $169 → $188 | $171.88 | +9.38% | 27 | Apr 24, 2026 | |
| PSX Phillips 66 | Upgrades: Overweight | $147 → $174 | $178.47 | -2.50% | 4 | Apr 24, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $375 → $395 | $370.75 | +6.54% | 4 | Apr 22, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $40 → $48 | $53.54 | -10.35% | 5 | Mar 4, 2026 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $22 → $24 | $22.51 | +6.62% | 13 | Feb 25, 2026 | |
| HUM Humana | Downgrades: Underweight | $262 → $174 | $237.96 | -26.88% | 6 | Feb 2, 2026 | |
| COR Cencora | Upgrades: Overweight | $361 → $400 | $303.66 | +31.73% | 2 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $224 → $245 | $197.06 | +24.33% | 13 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $38 | $21.14 | +79.75% | 2 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $359 → $352 | $371.90 | -5.35% | 5 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $93 | $82.01 | +13.40% | 7 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $211 → $175 | $112.68 | +55.31% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $857 → $916 | $807.85 | +13.39% | 10 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $765 → $805 | $563.12 | +42.95% | 19 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $54.68 | -52.45% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $279.35 | +39.61% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $2.27 | +40.97% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $11.20 | +105.36% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $191.50 | -10.18% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $253.01 | +18.57% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $7.99 | +425.66% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $174.04 | +65.48% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $172.32 | +104.27% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.79 | +1,060.95% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $417.02 | -56.60% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $87.78 | -80.63% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $24.56 | +392.67% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $462.60 | +25.38% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $6.19 | +465.43% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $111.97 | +83.08% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $15.12 | -27.25% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $160.94 | -2.45% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $518.15 | -40.56% | 1 | Oct 25, 2017 |
Henry Schein
Apr 24, 2026
Maintains: Underweight
Price Target: $61 → $64
Current: $72.02
Upside: -11.14%
Molina Healthcare
Apr 24, 2026
Maintains: Equal-Weight
Price Target: $128 → $146
Current: $195.53
Upside: -25.33%
Envista Holdings
Apr 24, 2026
Maintains: Equal-Weight
Price Target: $19 → $21
Current: $25.81
Upside: -18.64%
Align Technology
Apr 24, 2026
Maintains: Equal-Weight
Price Target: $169 → $188
Current: $171.88
Upside: +9.38%
Phillips 66
Apr 24, 2026
Upgrades: Overweight
Price Target: $147 → $174
Current: $178.47
Upside: -2.50%
UnitedHealth Group
Apr 22, 2026
Maintains: Overweight
Price Target: $375 → $395
Current: $370.75
Upside: +6.54%
BrightSpring Health Services
Mar 4, 2026
Maintains: Overweight
Price Target: $40 → $48
Current: $53.54
Upside: -10.35%
Elanco Animal Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $22 → $24
Current: $22.51
Upside: +6.62%
Humana
Feb 2, 2026
Downgrades: Underweight
Price Target: $262 → $174
Current: $237.96
Upside: -26.88%
Cencora
Jan 29, 2026
Upgrades: Overweight
Price Target: $361 → $400
Current: $303.66
Upside: +31.73%
Jan 29, 2026
Maintains: Overweight
Price Target: $224 → $245
Current: $197.06
Upside: +24.33%
Jan 13, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $21.14
Upside: +79.75%
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $371.90
Upside: -5.35%
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $82.01
Upside: +13.40%
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $112.68
Upside: +55.31%
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $807.85
Upside: +13.39%
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $563.12
Upside: +42.95%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $54.68
Upside: -52.45%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $279.35
Upside: +39.61%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $2.27
Upside: +40.97%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $11.20
Upside: +105.36%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $191.50
Upside: -10.18%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $253.01
Upside: +18.57%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $7.99
Upside: +425.66%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $174.04
Upside: +65.48%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $172.32
Upside: +104.27%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.79
Upside: +1,060.95%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $417.02
Upside: -56.60%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $87.78
Upside: -80.63%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $24.56
Upside: +392.67%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $462.60
Upside: +25.38%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $6.19
Upside: +465.43%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $111.97
Upside: +83.08%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $15.12
Upside: -27.25%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $160.94
Upside: -2.45%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $518.15
Upside: -40.56%